Answers are grounded in this paper and cite their sources.
The validation shows non-invasive estimation of pancreatic duct pressure in chronic pancreatitis, indicating associations with pain relief outcomes.
To develop and validate a non-invasive method to estimate pancreatic duct pressure (PDP) by integrating magnetic resonance cholangiopancreatography (MRCP)-derived anatomy with computational flow modeling and to assess its clinical relevance for identifying pancreatic ductal hypertension (PDH) in chronic pancreatitis. Three-dimensional pancreatic duct geometries were reconstructed from MRCP and used for computational fluid dynamics (CFD) simulations with physiologic wall-secretion boundary conditions. A quasi-one-dimensional analytical model was also derived to enable rapid PDP prediction from ductal geometry and flow. Prospective cases with endoscopic retrograde cholangiopancreatography (ERCP) manometry were used for validation, and a retrospective chronic pancreatitis (CP) cohort with documented pain-relief outcomes after decompression evaluated clinical utility. Simulated intraductal pressure distributions localized to anatomical strictures and showed a positive linear correlation with ERCP-measured pressure drops in the prospective subset. In the retrospective cohort, greater simulated pressure drops were associated with larger postoperative pain-relief scores. The quasi-1D model closely matched CFD across flow regimes and improved further with a non-linear inertial term. MRCP-based computational modeling enables non-invasive PDP estimation with promising agreement against invasive measurements and clinically meaningful association with symptom relief. The validated quasi-1D model supports rapid, clinically scalable assessment of PDH to inform patient selection and treatment planning.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: